CompletedNCT06888622

BLAZE-Limiting Approach in NMOSD

Studying Neuromyelitis Optica

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Huashan Hospital
Principal Investigator
Chao Quan, Doctor
Department of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China
Intervention
Eculizumab administration(drug)
Enrollment
9 enrolled
Eligibility
18 years · All sexes
Timeline
2023 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06888622 on ClinicalTrials.gov

Other trials for Neuromyelitis Optica

Additional recruiting or active studies for the same condition.

See all trials for Neuromyelitis Optica →

← Back to all trials